OH HB384

Amends sections 1751.66 and 3923.60 of the Revised Code to reference compendia adopted by the U.S. Department of Health and Human Services under 42 U.S.C. 1395x(t)(2) instead of specifying individual publications like AMA drug evaluations, AHFS drug information, and USP drug information.

Prohibits health insurers and sickness and accident insurers from excluding coverage for FDA-approved drugs used off-label if the drug is recognized as safe and effective in the adopted federal compendia or in medical literature meeting specified criteria.

Medical literature may qualify for off-label coverage if two peer-reviewed articles recognize drug safety and effectiveness, no articles conclude the drug is unsafe or ineffective, and articles meet uniform manuscript requirements or are published in journals specified by the U.S. Department of Health and Human Services.

Carves out exceptions preventing coverage requirements for drugs the FDA has determined contraindicated, experimental drugs not approved for any indication, or drugs excluded from formularies for reasons unrelated to off-label coverage requirements.

Applies to individual and group health insurance policies and sickness and accident insurance policies delivered or renewed in Ohio on or after the effective date of the amendment.